Evidence-gap map · non-drug interventions

Ischemic Stroke evidence gaps

297 registered non-drug trials, mapped by approach and outcome.

Which non-drug approaches have been tested for Ischemic Stroke, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

297registered non-drug trials
21with results posted
74recruiting as of 2026-11-16
116group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition. The registry search returned 1,665 trials, more than the 1,000-trial cap, so this map covers the most recently updated 1,000.

none1–23–910–2930 or more
Registered non-drug trials for Ischemic Stroke by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (43)21 with results·31 with results41 with results1·202 with results21 with results222331 with results112 with results113 with results7
Rehabilitation and therapy services (65)1·675·271 with results14513818511
Breathing and respiratory training (1)········1·····1·
Mind-body and psychological approaches (18)11 with results·31 with results41 with results·151 with results11 with results·3·121 with results31 with results41 with results1
Cognitive training and education (18)1·53··531 with results·31 with results··372 with results131 with results
Diet, fasting and nutrition (3)······1···1···1·
Sleep and circadian approaches (5)·····1·11··12211 with results·
Neuromodulation and electrical stimulation (68)1·624116213271 with results1121102 with results13
Oxygen, light, temperature and manual therapies (33)21 with results·11 with results11 with results1181 with results1···531 with results111 with results49
Supplements and nutraceuticals (20)··11··421·133642
Other devices and digital tools (11)··12··3···1·2214
Care delivery and health services (9)··1···121 with results····121 with results61
Other behavioural, not yet classified (47)21 with results·11 with results31 with results··93 with results81 with results·131 with results·51 with results162 with results114 with results111 with results

The table scrolls sideways: 16 outcome columns.

Where the gaps are

This condition has 1,665 matching trials, more than the 1,000 this map covers, so it cannot show that an outcome was never measured. Only studied-but-unreported questions are listed.

Questions studied but with no results posted

  • Neuromodulation and electrical stimulation × clinical events, survival and healthcare use: 21 trials registered, none with results posted (10 still recruiting)
  • Rehabilitation and therapy services × clinical events, survival and healthcare use: 18 trials registered, none with results posted (4 still recruiting)
  • Neuromodulation and electrical stimulation × physical function and exercise capacity: 16 trials registered, none with results posted (6 still recruiting)
  • Neuromodulation and electrical stimulation × symptom severity and disease activity: 11 trials registered, none with results posted (5 still recruiting)
  • Rehabilitation and therapy services × symptom severity and disease activity: 8 trials registered, none with results posted (1 still recruiting)
  • Rehabilitation and therapy services × mood, anxiety and wellbeing: 7 trials registered, none with results posted (2 still recruiting)
  • Rehabilitation and therapy services × cognition: 6 trials registered, none with results posted (3 still recruiting)
  • Neuromodulation and electrical stimulation × cognition: 6 trials registered, none with results posted (2 still recruiting)
  • Supplements and nutraceuticals × clinical events, survival and healthcare use: 6 trials registered, none with results posted (2 still recruiting)
  • Care delivery and health services × feasibility, adherence and safety: 6 trials registered, none with results posted (2 still recruiting)
  • Rehabilitation and therapy services × pain: 5 trials registered, none with results posted (1 still recruiting)
  • Rehabilitation and therapy services × quality of life: 5 trials registered, none with results posted
  • Rehabilitation and therapy services × feasibility, adherence and safety: 5 trials registered, none with results posted (1 still recruiting)
  • Cognitive training and education × cognition: 5 trials registered, none with results posted

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Ischemic Stroke

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 55 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.